| 228 The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation.
227 Nontoxic radioactive Listeria is a highly effective therapy against metastatic pancreatic cancer.
226 MicroRNA profiling of 1,302 human breast tumour samples provides an overview of the miRNA landscape and its regulation, revealing context-dependent interactions, broad prognostic value of miRNA signatures and an important modulatory role for miRNAs in the biology of breast tumours devoid of copy-number aberrations.
225 The oncolytic and immunotherapeutic vaccinia virus Pexa-Vec (JX-594) induces antibody-mediated complement-dependent cancer cell cytolysis in rabbits and cancer patients, prolonging their survival.
224 Mutations of histones in some cancers result in inhibition of enzymes that lay down epigenetic marks on chromatin.
223 Cyclophosphamide Triggers Follicle Activation and “Burnout”; AS101 Prevents Follicle Loss and Preserves Fertility.
222 In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras–effector interaction.
221 Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
220 Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.
219 A Novel Fully Automated Molecular Diagnostic System (AMDS) for Colorectal Cancer Mutation Detection.
218 Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer.
217 Neural stem cells home to gliomas in mice where they convert a prodrug to 5-fluorouracil, leading to tumor regression.
216 Silica-Based Branched Hollow Microfibers as a Biomimetic Extracellular Matrix for Promoting Tumor Cell Growth In Vitro and In Vivo.
215 A small molecule that inhibits a mutant enzyme in tumors slows malignant growth by inducing cancer cell differentiation.
214 Epigenetic changes contribute to a positive feedback loop promoting AP1 activity that contributes to metastasis of squamous cell carcinoma to lymph nodes.
213 Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.
212 Punctuated Evolution of Prostate Cancer Genomes.
211 Specific Capture and Release of Circulating Tumor Cells Using Aptamer-Modified Nanosubstrates.
210 Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle.
209 Laponite Nanodisks as an Efficient Platform for Doxorubicin Delivery to Cancer Cells.